Rashed Abdullah

874 total citations
10 papers, 684 citations indexed

About

Rashed Abdullah is a scholar working on Molecular Biology, Neurology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Rashed Abdullah has authored 10 papers receiving a total of 684 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Neurology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Rashed Abdullah's work include Parkinson's Disease Mechanisms and Treatments (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Neurological diseases and metabolism (2 papers). Rashed Abdullah is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Neurological diseases and metabolism (2 papers). Rashed Abdullah collaborates with scholars based in United States, Norway and Canada. Rashed Abdullah's co-authors include Paul Kussie, Zhenping Zhu, Peter Böhlen, Daniel J. Hicklin, Danielle P. Johnson, Xenia Jimenez, Henry Koo, Rajiv Bassi, Marie Prewett and Dan Lu and has published in prestigious journals such as Blood, Journal of Virology and Vaccine.

In The Last Decade

Rashed Abdullah

10 papers receiving 655 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rashed Abdullah United States 8 364 181 113 102 93 10 684
Adam Master Poland 12 245 0.7× 61 0.3× 119 1.1× 122 1.2× 104 1.1× 35 664
Kaijin Wu United States 18 366 1.0× 85 0.5× 70 0.6× 82 0.8× 127 1.4× 29 819
Aleth Callé France 14 610 1.7× 59 0.3× 68 0.6× 97 1.0× 139 1.5× 22 959
Mohammed Kanchwala United States 14 356 1.0× 31 0.2× 119 1.1× 101 1.0× 89 1.0× 27 653
René Hubert United States 10 541 1.5× 27 0.1× 114 1.0× 195 1.9× 192 2.1× 17 1.1k
Qiushi Tang United States 18 647 1.8× 38 0.2× 145 1.3× 68 0.7× 185 2.0× 34 1.0k
Mert Icyuz United States 12 435 1.2× 40 0.2× 302 2.7× 258 2.5× 50 0.5× 21 801
Marı́a Fedetz Spain 18 272 0.7× 34 0.2× 65 0.6× 397 3.9× 151 1.6× 33 887
Rodolfo Frunzio Italy 15 625 1.7× 255 1.4× 80 0.7× 114 1.1× 71 0.8× 17 895
Thomas Mayr Germany 11 350 1.0× 40 0.2× 77 0.7× 67 0.7× 105 1.1× 20 600

Countries citing papers authored by Rashed Abdullah

Since Specialization
Citations

This map shows the geographic impact of Rashed Abdullah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rashed Abdullah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rashed Abdullah more than expected).

Fields of papers citing papers by Rashed Abdullah

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rashed Abdullah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rashed Abdullah. The network helps show where Rashed Abdullah may publish in the future.

Co-authorship network of co-authors of Rashed Abdullah

This figure shows the co-authorship network connecting the top 25 collaborators of Rashed Abdullah. A scholar is included among the top collaborators of Rashed Abdullah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rashed Abdullah. Rashed Abdullah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Quijano, Elias, Zaira Ianniello, Rashed Abdullah, et al.. (2024). Next-generation cell-penetrating antibodies for tumor targeting and RAD51 inhibition. Oncotarget. 15(1). 699–713. 2 indexed citations
2.
Abdullah, Rashed, et al.. (2021). Accelerated antibody discovery targeting the SARS-CoV-2 spike protein for COVID-19 therapeutic potential. PubMed. 4(3). 185–196. 5 indexed citations
3.
Abdullah, Rashed, Ketan S. Patil, Benjamin Rosen, et al.. (2016). Subcellular Parkinson’s Disease-Specific Alpha-Synuclein Species Show Altered Behavior in Neurodegeneration. Molecular Neurobiology. 54(10). 7639–7655. 9 indexed citations
4.
Prabhudesai, Shubhangi, Rashed Abdullah, Indranil Basak, et al.. (2016). LRRK2 knockdown in zebrafish causes developmental defects, neuronal loss, and synuclein aggregation. Journal of Neuroscience Research. 94(8). 717–735. 37 indexed citations
5.
Abdullah, Rashed, Indranil Basak, Ketan S. Patil, et al.. (2014). Parkinson's disease and age: The obvious but largely unexplored link. Experimental Gerontology. 68. 33–38. 59 indexed citations
6.
Patil, Ketan S., Indranil Basak, Sungsu Lee, et al.. (2014). PARK13 regulates PINK1 and subcellular relocation patterns under oxidative stress in neurons. Journal of Neuroscience Research. 92(9). 1167–1177. 16 indexed citations
7.
8.
Luckay, Amara, Maninder K. Sidhu, Rune Kjeken, et al.. (2007). Effect of Plasmid DNA Vaccine Design and In Vivo Electroporation on the Resulting Vaccine-Specific Immune Responses in Rhesus Macaques. Journal of Virology. 81(10). 5257–5269. 154 indexed citations
9.
May, Chad, Jacqueline Doody, Rashed Abdullah, et al.. (2005). Identification of a transiently exposed VE-cadherin epitope that allows for specific targeting of an antibody to the tumor neovasculature. Blood. 105(11). 4337–4344. 80 indexed citations
10.
Burtrum, Douglas, Zhenping Zhu, Dan Lu, et al.. (2003). A fully human monoclonal antibody to the insulin-like growth factor I receptor blocks ligand-dependent signaling and inhibits human tumor growth in vivo.. PubMed. 63(24). 8912–21. 298 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Adam Master Breakdown of academic impact, for papers by Kaijin Wu Breakdown of academic impact, for papers by Aleth Callé Breakdown of academic impact, for papers by Mohammed Kanchwala Breakdown of academic impact, for papers by René Hubert Breakdown of academic impact, for papers by Qiushi Tang Breakdown of academic impact, for papers by Mert Icyuz Breakdown of academic impact, for papers by Marı́a Fedetz Breakdown of academic impact, for papers by Rodolfo Frunzio Breakdown of academic impact, for papers by Thomas Mayr
Rankless by CCL
2026